Not logged in Share Save
Share Save
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) (vol 7, 100552, 2024) Hartlapp, I.; Valta-Seufzer, D.; Siveke, J. T.; Alguel, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V.; Kunzmann, V. Share Save
Nab-paclitaxel/gemcitabine with or without epigenetic targeting followed by consolidating immune targeting with durvalumab and lenalidomide in patients with advanced pancreatic ductal adenocarcinoma: Results from the SEPION/AIO-PAK-0118 phase I/II study Siveke, J. T.; Sinn, M.; Dorman, K.; Siegler, G. M.; Seufferlein, T.; Trojan, J.; Waldschmidt, D. T.; Koenig, A. O.; Schipp, D.; Liffers, S-T.; Kunzmann, V. Share Save
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) (vol 7, 100552, 2024) Hartlapp, I.; Valta-Seufzer, D.; Siveke, J. T.; Alguel, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V.; Kunzmann, V. Share Save
ASO Visual Abstract: Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer-The Randomized Multicenter Phase II NEPAFOX Trial Goetze, Thorsten O.; Reichart, Alexander; Bankstahl, Ulli S.; Pauligk, Claudia; Loose, Maria; Kraus, Thomas W.; Elshafei, Moustafa; Bechstein, Wolf O.; Trojan, Joerg; Behrend, Matthias; Homann, Nils; Venerito, Marino; Bohle, Wolfram; Varvenne, Michael; Bolling, Claus; Behringer, Dirk M.; Kratz-Albers, Karsten; Siegler, Gabriele M.; Hozaeel, Wael; Al-Batran, Salah-Eddin Share Save
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial Goetze, Thorsten O.; Reichart, Alexander; Bankstahl, Ulli S.; Pauligk, Claudia; Loose, Maria; Kraus, Thomas W.; Elshafei, Moustafa; Bechstein, Wolf O.; Trojan, Joerg; Behrend, Matthias; Homann, Nils; Venerito, Marino; Bohle, Wolfram; Varvenne, Michael; Bolling, Claus; Behringer, Dirk M.; Kratz-Albers, Karsten; Siegler, Gabriele M.; Hozaeel, Wael; Al-Batran, Salah-Eddin Share Save
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321) Tintelnot, Joseph; Stein, Alexander; Al-Batran, Salah-Eddin; Ettrich, Thomas; Goetze, Thorsten; Gruen, Barbara; Haag, Georg Martin; Heuer, Vera; Hofheinz, Ralf-Dieter; Homann, Nils; Broering, Tobias Sebastian; Cruz, Mariana Santos; Kurreck, Annika; Lorenzen, Sylvie; Moosmann, Nicolas; Mueller, Christian; Schuler, Markus; Siegler, Gabriele; Binder, Mascha; Goekkurt, Eray Share Save
Predictive factors for treatment success of second-line NalIRI/5-FU/FA in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) (AIO-PAK-0216) Lutz, M. P.; Ansorge, N.; Barmashenko, G.; Burkart, C.; Decker, T.; Ettrich, T. J.; von Weikersthal, L. Fischer; Geer, T.; Gerhardt, A.; Hoefling, S.; Jacobasch, L.; Karthaus, M.; Koenigsmann, M. P.; Leidig, T.; Schulte, M.; Schulte, N.; Schwarzer, A.; Siegler, G. M.; Waldschmidt, D. T.; Raeth, S. Share Save
IMMUNIB trial (AIO-HEP-0218/ass): A single-arm phase II study evaluating safety and efficacy of immunotherapy with nivolumab in combination with lenvatinib in advanced hepatocellular carcinoma Vogel, A.; Saborowski, A.; Siegler, G. M.; Siebler, J.; Lindig, U.; Schultheiss, M.; Mueller, T.; Simon, H.; Joeckel, C.; Muller, D. W.; Al-Batran, S-E.; De Toni, E. Share Save
Interim safety results from SEPION/AIO-PAK-0118: A multicenter, Phase I/II study of sequential epigenetic and immune targeting in combination with nabpaclitaxel/gemcitabine in patients with advanced pancreatic ductal adenocarcinoma Siveke, Jens T.; Sinn, Marianne; Boeck, Stefan; Siegler, Gabriele; Seufferlein, Thomas; Trojan, Joerg; Waldschmidt, Dirk; Koenig, Alexander; Schipp, Dorothea; Winkler, Ines; Liffers, Sven Thorsten; Kunzmann, Volker Share Save
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM Goetze, Thorsten O.; Hofheinz, Ralf-Dieter; Gaiser, Timo; Schmalenberg, Harald; Strumberg, Dirk; Goekkurt, Eray; Angermeier, Stefan; Zander, Thomas; Kopp, Hans G.; Pink, Daniel; Siegler, Gabriele; Schenk, Michael; de Vita, Ferdinando; Galizia, Gennaro; Maiello, Evaristo; Bechstein, Wolf O.; Elshafei, Moustafa; Loose, Maria; Sookthai, Disorn; Brulin, Tanita; Pauligk, Claudia; Homann, Nils; Al-Batran, Salah-Eddin Share Save
Radiochemotherapy with gemcitabine as a radiosensitizer in patients with soft tissue sarcomas Schneider, L.; Albrecht, C.; Grehn, C.; Gryc, T.; Knop, S.; Siegler, G.; Bott, A.; Rottmann, M.; Blos, M.; Linnemann, U.; Koehler, J.; Jakob, J.; Hohenberger, P.; Papadopoulos, T.; Meyer, C.; Mordstein, V.; Stein, B.; Gazdag, L.; Reichert, B.; Augustin, M. Share Save
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) Hartlapp, I; Valta-Seufzer, D.; Siveke, J. T.; Algul, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V; Kunzmann, V Share Save
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multi-agent induction chemotherapy: Results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) Hartlapp, I.; Valta-Seufzer, D.; Siveke, J.; Alguel, H.; Goekkurt, E.; Siegler, G. M.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C-T.; Stang, H. A.; Heinemann, V.; Kunzmann, V. Share Save
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial Kunzmann, Volker; Siveke, Jens T.; Alguel, Hana; Goekkurt, Eray; Siegler, Gabriele; Martens, Uwe; Waldschmidt, Dirk; Pelzer, Uwe; Fuchs, Martin; Kullmann, Frank; Boeck, Stefan; Ettrich, Thomas J.; Held, Swantje; Keller, Ralph; Klein, Ingo; Germer, Christoph-Thomas; Stein, Hubert; Friess, Helmut; Bahra, Marcus; Jakobs, Ralf; Hartlapp, Ingo; Heinemann, Volker Share Save
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry Al-Batran, Salah-Eddin; Hofheinz, Ralf-Dieter; Reichart, Alexander; Pauligk, Claudia; Schoenherr, Caroline; Schlag, Rudolf; Siegler, Gabriele; Doerfel, Steffen; Koenigsmann, Michael; Zahn, Mark-Oliver; Schubert, Joerg; Aldaoud, Ali; Hoeffkes, Heinz-Gert; Schulz, Holger; Hahn, Lars; Uhlig, Jens; Blau, Wolfgang; Stauch, Martina; Weniger, Joerg; Wolf, Martin; Jacobasch, Lutz; Bildat, Stephan; Wehmeyer, Juergen; Homann, Nils; Trojan, Joerg; Waidmann, Oliver; Fietz, Thomas; Feustel, Hans-Peter; Groschek, Matthias; Wierecky, Jan; Waibel, Karin; Mahlmann, Stefan; Schwindel, Uwe; Peters, Uwe; Schuch, Gunter; Pink, Daniel; Eschenburg, Henning; Woerns, Marcus-A.; Harich, Hans-Detlev; von Weikersthal, Ludwig Fischer; Daessler, Klaus-Ulrich; Behringer, Dirk M.; Messmann, Helmut; Kretzschmar, Albrecht; Gallmeier, Eike; Forstbauer, Helmut; Kunzmann, Volker; Papke, Jens; Buechner-Steudel, Petra; Vehling-Kaiser, Ursula; Springfeld, Christoph; Vogel, Arndt; Ettrich, Thomas J.; Schaaf, Marina; zur Hausen, Gerrit; Goetze, Thorsten Oliver Share Save
Safety analysis of the run-in phase (1st and 2nd cohort) of the IMMUNIB trial (AIO-HEP-0218/ass) - An open-label, single-arm phase II study evaluating safety and efficacy of immunotherapy with nivolumab in combination with lenvatinib in advanced stage HCC Vogel, A.; Mueller, D. W.; De Toni, E.; Siegler, G. M.; Siebler, J.; Lindig, U.; Mueller, T.; Schultheiss, M.; Geissler, M.; Krammer-Steiner, B.; Reichart, A.; Lammert, F.; Prause, C.; Walker, M.; Al-Batran, S-E.; Kosic, N. Share Save
The QOLIXANE trial - Real life QoL and efficacy data in 1st line pancreatic cancer from the prospective platform for outcome, quality of life, and translational research on pancreatic cancer (PARAGON) registry Goetze, T. O.; Hofheinz, R. D.; Reichart, A.; Pauligk, C.; Schlag, R.; Siegler, G. M.; Hoeffkes, H-G.; Blau, W.; Homann, N.; Trojan, J.; Waidmann, O.; Pink, D.; Messmann, H.; Kunzmann, V.; Vogel, A.; Ettrich, T. J.; Schoenherr, C.; Schaaf, M.; zur Hausen, G.; Al-Batran, S-E. Share Save
Final results and subgroup analysis of the PETRARCA randomized phase II AIO trial: Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2 positive resectable esophagogastric adenocarcinoma Al-Batran, S-E.; Haag, G. M.; Ettrich, T. J.; Borchert, K.; Kretzschmar, A.; Teschendorf, C.; Siegler, G. M.; Ebert, M.; Goekkurt, E.; Welslau, M. K.; Mahlberg, R. J. C.; Homann, N.; Pink, D.; Bechstein, W. O.; Reichardt, P.; Gaiser, T.; Sookthai, D.; Pauligk, C.; Goetze, T. O.; Hofheinz, R. D. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
